Enorama Pharma AB Capital Reinvestment Ratio
Enorama Pharma AB capital reinvestment ratio. Enorama Pharma AB (ERMA) has a Capital Reinvestment Ratio of 4.15x as of December 2015, meaning it reinvests 4% of its operating cash flow (Skr480.00K) in capital expenditures (Skr1.99 Million). Check total reinvestment intensity of Enorama Pharma AB to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Enorama Pharma AB (2014–2015)
Capital reinvestment ratio of Enorama Pharma AB from 2014 to 2015. This chart tracks Enorama Pharma AB's Capital Reinvestment Ratio across 2 annual periods. Also explore how fast is Enorama Pharma AB growing its equity to track the company's year-over-year net asset growth rate.
Enorama Pharma AB Capital Reinvestment Ratio by Year (2014–2015)
Enorama Pharma AB capital reinvestment ratio by year from 2014 to 2015. For the full cash flow conversion analysis, see Enorama Pharma AB (ERMA) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 4.15x | Skr480.00K | Skr1.99 Million | ▼ -7.8% |
| 2014 | 4.50x | Skr307.00K | Skr1.38 Million | — |